- Neptune Technologies & Bioressources Inc. enters into an exclusive distribution agreement with AZPA International Inc. for Australia and New
LAVAL, QC, Dec. 19 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) is pleased to announce that it has entered into an exclusive distribution agreement with AZPA International Inc. ("AZPA International") for Australia and New Zealand. AZPA International, a leading supplier to the pharmaceutical, nutritional health and cosmetics industries, has also acquired non-exclusive rights to commercialize Neptune's products in Southeast Asia and Hong Kong.
The nationwide product launch of Neptune Krill Oil (NKO(R)) in Australia and New Zealand, claiming cardiovascular and joint health benefits, is scheduled for February 2008. A pre-requisite for commercializing NKO(R) in Australia hence New Zealand is obtaining approval as a complementary medicine from the Therapeutic Goods Administration (TGA) which notification Neptune has recently announced.
AZPA International joined forces for the commercialization and distribution of NKO(R) with PharmaLink Pte. Ltd. ("PharmaLink"), a leading provider of complementary and over-the-counter medicines and a leader in healthcare sales and marketing in the Asia-Pacific region. PharmaLink will be reaching the market through its primary care team, its pharmacy/ OTC team and its specialist/ allied health team.
"It is estimated that 74% of the Australian population has used
complementary medicine in the previous twelve months and usage rates are
expected to rise,(1)" said Thierry Houillon, Vice President of
Nutraceuticals of Neptune. "An estimated annual increase of 18% has been
reported for the complementary medicine market in Australia.(2) We are
looking forward to working with AZPA International and PharmaLink
benefiting from this trend and making NKO(R) a household name
|SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.|
Copyright©2007 PR Newswire.
All rights reserved